Levetiracetam prevents Aβ42 production through SV2a-dependent modulation of App processing in Alzheimer's disease models.
Rao NR, DeGulis O, Nomura T, Lee S, Hark TJ, Dynes JC, Dexter EX, Dulewicz M, Ge J, Upadhyay A, Fornasiero EF, Vassar R, Hanrieder J, Contractor A, Savas JN.
Rao NR, et al.
bioRxiv [Preprint]. 2024 Oct 28:2024.10.28.620698. doi: 10.1101/2024.10.28.620698.
bioRxiv. 2024.
PMID: 39554163
Free PMC article.
Preprint.